Return On Equity of Neurogene Inc. from 30 Sep 2014 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Neurogene Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2014 to 30 Sep 2025.
  • Neurogene Inc. Return On Equity for the quarter ending 30 Sep 2025 was -30%, a 15% decline year-over-year.
  • Neurogene Inc. annual Return On Equity for 2024 was -39%, a 187% decline from 2023.
  • Neurogene Inc. annual Return On Equity for 2023 was 45%.
  • Neurogene Inc. annual Return On Equity for 2022 was -107%, a 80% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Neurogene Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -30% -4% -15% 01 Jul 2025 30 Sep 2025
Q2 2025 -33% +11% +25% 01 Apr 2025 30 Jun 2025
Q1 2025 -36% +2582% +99% 01 Jan 2025 31 Mar 2025
Q4 2024 -39% -47% -602% 01 Oct 2024 31 Dec 2024
Q3 2024 -26% -56% -185% 01 Jul 2024 30 Sep 2024
Q2 2024 -44% -97% -184% 01 Apr 2024 30 Jun 2024
Q1 2024 -2618% -2875% -1117% 01 Jan 2024 31 Mar 2024
Q4 2023 8% +115% 19 Dec 2023 31 Dec 2023
Q3 2023 30% +121% 01 Jul 2023 30 Sep 2023
Q2 2023 53% +132% 01 Apr 2023 30 Jun 2023
Q1 2023 257% +325% 01 Jan 2023 31 Mar 2023
Q4 2022 -107% -47% -80% 01 Oct 2022 31 Dec 2022
Q3 2022 -91% -57% -171% 01 Jul 2022 30 Sep 2022
Q2 2022 -80% -55% -226% 01 Apr 2022 30 Jun 2022
Q1 2022 -68% -45% -200% 01 Jan 2022 31 Mar 2022
Q4 2021 -59% -39% -193% 01 Oct 2021 31 Dec 2021
Q3 2021 -34% -15% -78% 01 Jul 2021 30 Sep 2021
Q2 2021 -24% +48% +66% 01 Apr 2021 30 Jun 2021
Q1 2021 -23% +50% +69% 01 Jan 2021 31 Mar 2021
Q4 2020 -20% +59% +74% 01 Oct 2020 31 Dec 2020
Q3 2020 -19% +75% +80% 01 Jul 2020 30 Sep 2020
Q2 2020 -72% -42% 01 Apr 2020 30 Jun 2020
Q1 2020 -73% -48% -195% 01 Jan 2020 31 Mar 2020
Q4 2019 -79% -40% -103% 01 Oct 2019 31 Dec 2019
Q3 2019 -93% -45% -91% 01 Jul 2019 30 Sep 2019
Q2 2019 -30%* +11% 01 Apr 2019 30 Jun 2019
Q1 2019 -25% +29% +54% 01 Jan 2019 31 Mar 2019
Q4 2018 -39% +4% +8.3% 01 Oct 2018 31 Dec 2018
Q3 2018 -49% -14% -41% 01 Jul 2018 30 Sep 2018
Q2 2018 -41% -11% -38% 01 Apr 2018 30 Jun 2018
Q1 2018 -53% -24% -83% 01 Jan 2018 31 Mar 2018
Q4 2017 -42% -12% -41% 01 Oct 2017 31 Dec 2017
Q3 2017 -35% -7% -27% 01 Jul 2017 30 Sep 2017
Q2 2017 -30% -2% -8.8% 01 Apr 2017 30 Jun 2017
Q1 2017 -29% -4% -15% 01 Jan 2017 31 Mar 2017
Q4 2016 -30% +1% +4.7% 01 Oct 2016 31 Dec 2016
Q3 2016 -27% +20% +42% 01 Jul 2016 30 Sep 2016
Q2 2016 -27% +48% +64% 01 Apr 2016 30 Jun 2016
Q1 2016 -25% +40% +61% 01 Jan 2016 31 Mar 2016
Q4 2015 -31% +20% +39% 01 Oct 2015 31 Dec 2015
Q3 2015 -47% +46% +50% 01 Jul 2015 30 Sep 2015
Q2 2015 -75% 01 Apr 2015 30 Jun 2015
Q1 2015 -65% 01 Jan 2015 31 Mar 2015
Q4 2014 -52% 01 Oct 2014 31 Dec 2014
Q3 2014 -93% 01 Jul 2014 30 Sep 2014

Neurogene Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -39% -84% -187% 01 Jan 2024 31 Dec 2024
2023 45% +152% 01 Jan 2023 31 Dec 2023
2022 -107% -47% -80% 01 Jan 2022 31 Dec 2022
2021 -59% -39% -193% 01 Jan 2021 31 Dec 2021
2020 -20% +59% +74% 01 Jan 2020 31 Dec 2020
2019 -79% -40% -103% 01 Jan 2019 31 Dec 2019
2018 -39% +4% +8.3% 01 Jan 2018 31 Dec 2018
2017 -42% -12% -41% 01 Jan 2017 31 Dec 2017
2016 -30% +1% +4.7% 01 Jan 2016 31 Dec 2016
2015 -31% +20% +39% 01 Jan 2015 31 Dec 2015
2014 -52% 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.